Just what the fuck is your doctors protocol to prevent dementia/Alzheimers? You have a decent chance of getting it. Does your doctor even know about this research? Or is your doctor waiting until resveratrol tomatoes come along so alcohol doesn't have to be prescribed? That answer tells you if you should fire that doctor or not.
Your chances of getting dementia.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
A molecule found in red wine may be the key to slowing the progression of Alzheimer’s, new findings presented Wednesday suggest.
Resveratrol, a compound found in red wine, red
grapes, raspberries, and chocolate, appears to repair “leaky”
blood-brain barriers, which allow blood from the body to enter the
brain. This repair slowed the advancement of cognitive problems in
Alzheimer’s patients, according to a study from Georgetown University
Medical Center.
The brains of patients with Alzheimer’s are often
further damaged by nervous tissue inflammation, which is associated with
neuron degradation and cognitive decline. This inflammation is
partially caused by the secretion of harmful immune molecules from the
body into the brain through a permeable blood-brain barrier.
Study authors found that resveratrol appears to
restore the integrity of the blood-brain barrier, keeping the harmful
immune molecules out of the brain.
“These findings suggest that resveratrol imposes a
kind of crowd control at the border of the brain. The agent seems to
shut out unwanted immune molecules that can exacerbate brain
inflammation and kill neurons,” study author Dr. Charbel Moussa,
scientific and clinical research director of the Georgetown Medical
Center Translational Neurotherapeutics Program, said in the news
release.
“These are very exciting findings because it shows that
resveratrol engages the brain in a measurable way, and that the immune
response to Alzheimer’s disease comes, in part, from outside the brain.”
The results, presented at the Alzheimer’s Association
International Conference in Toronto, built off of a study from
Georgetown Medical Center on resveratrol in individuals with mild to
moderate Alzheimer’s, published last year in
Neurology.
The new aspects of the study examined the
cerebrospinal fluid of 38 individuals with Alzheimer’s. Half of the
participants were given a placebo, and the other half were treated daily
with resveratrol for a year. According to researchers, this amount of
resveratrol
equated to the amount found in approximately 1,000 bottles
of red wine. (Is that a daily dose of 1000 bottles of wine?)
Researchers saw a 50 percent reduction in the levels
of a molecule known as matrix metalloproteinase-9 (MMP-9) in the
cerebrospinal fluid. High levels of MMP-9 result in the breakdown of the
blood-brain barrier and the leakage of harmful immune molecules through
it. Low levels of MMP-9, researchers assert, maintain the barrier more
effectively.
“These new findings are exciting because they
increase our understanding of how resveratrol may be clinically
beneficial to individuals with Alzheimer’s disease,” lead researcher R.
Scott Turner, director of Georgetown Medical Center’s Memory Disorders
Program and co-director of the Translational Neurotherapeutics Program,
said in the news release. “In particular, they point to the important
role of inflammation in the disease, and the potent anti-inflammatory
effects of resveratrol.”
Researchers noted that resveratrol should be further
tested in clinical settings; however, they do not see the molecule
itself becoming a complete treatment for Alzheimer’s. Instead, Turner
said, researchers hope to combine the molecule with a separate agent
that can target specific Alzheimer’s-causing proteins in the brain.